Azathioprine in Recurrent Implantation Failure

Phase 2CompletedNCT03498703

Ain Shams University64 enrolled

Overview

Azathioprine increase pregnancy rate in patients with recurrent implantation failure

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Recurrent Implantation Failure In Vitro Fertilization Intracytoplsmic Sperm Injection

Interventions

Azathioprine PillDRUG

Azathioprine increase pregnancy rate in cases with recurrent implantaion failure

Placebo Oral TabletDRUG

Placebo tablets

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 39 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age: 20-39 * previous 3 or more failed ivf Exclusion Criteria: * intrauterine anomalies * chronic systemic illness * chronic pelvic conditions * sensitivety to azathioprine

Locations (2)

Ain Shams University, Maternity Hospital

Cairo, Egypt

Capital Birth Center

Cairo, Egypt

Outcomes

Primary Outcomes

Clinical pregnancy rate

Time frame: 2 weeks

Secondary Outcomes

Side effects

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.